###begin article-title 0
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 85 91 85 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+ </sup>
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
The pro-apoptotic K-Ras 4A proto-oncoprotein does not affect tumorigenesis in the ApcMin/+ mouse small intestine
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 196 200 196 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 336 340 336 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 401 405 401 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 515 523 515 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">absence </italic>
###xml 562 565 562 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 565 571 565 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+ </sup>
###xml 572 575 572 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 652 656 652 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 688 691 688 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 691 711 691 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
###xml 740 744 732 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 840 843 832 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 843 848 835 840 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 852 855 844 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 855 859 847 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 863 866 855 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 866 871 858 863 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 875 878 867 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 878 898 870 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
###xml 939 943 923 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 577 582 <span type="species:ncbi:10090">mouse</span>
###xml 711 716 <span type="species:ncbi:10090">mouse</span>
###xml 898 902 <span type="species:ncbi:10090">mice</span>
Alterations in gene splicing occur in human sporadic colorectal cancer (CRC) and may contribute to tumour progression. The K-ras proto-oncogene encodes two splice variants, K-ras 4A and 4B, and K-ras activating mutations which jointly affect both isoforms are prevalent in CRC. Past studies have established that splicing of both the K-ras oncogene and proto-oncogene is altered in CRC in favour of K-ras 4B. The present study addressed whether the K-Ras 4A proto-oncoprotein can suppress tumour development in the absence of its oncogenic allele, utilising the ApcMin/+ (Min) mouse that spontaneously develops intestinal tumours that do not harbour K-ras activating mutations, and the K-rastmDelta4A/tmDelta4A mouse that can express the K-ras 4B splice variant only. By this means tumorigenesis in the small intestine was compared between ApcMin/+, K-ras+/+ and ApcMin/+, K-rastmDelta4A/tmDelta4A mice that can, and cannot, express the K-ras 4A proto-oncoprotein respectively.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 182 185 182 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 185 190 185 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 194 197 194 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 197 201 197 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 205 208 205 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 208 213 208 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 217 220 217 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 220 240 220 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
###xml 415 416 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 597 601 589 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
The relative levels of expression of the K-ras splice variants in normal small intestine and small intestinal tumours were quantified by real-time RT-qPCR analysis. Inbred (C57BL/6) ApcMin/+, K-ras+/+ and ApcMin/+, K-rastmDelta4A/tmDelta4A mice were generated and the genotypes confirmed by PCR analysis. Survival of stocks was compared by the Mantel-Haenszel test, and tumour number and area compared by Student's t-test in outwardly healthy mice at approximately 106 and 152 days of age. DNA sequencing of codons 12, 13 and 61 was performed to confirm the intestinal tumours did not harbour a K-ras activating mutation.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 112 116 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 255 259 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 286 290 286 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 363 367 363 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 387 391 387 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 432 437 <span type="species:ncbi:10090">mouse</span>
The K-ras 4A transcript accounted for about 50% of K-ras expressed in the small intestine of both wild-type and Min mice. Tumours in the small intestine of Min mice showed increased levels of K-ras 4B transcript expression, but no appreciable change in K-ras 4A transcript levels. No K-ras activating mutations were detected in 27 intestinal tumours derived from Min and compound mutant Min mice. K-Ras 4A deficiency did not affect mouse survival, or tumour number, size or histopathology.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 166 170 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
The K-Ras 4A proto-oncoprotein does not exhibit tumour suppressor activity in the small intestine, even though the K-ras 4A/4B ratio is reduced in adenomas lacking K-ras activating mutations.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 305 306 305 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 557 558 557 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 559 560 559 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
The development of sporadic colorectal cancer (CRC) involves genetic and epigenetic changes, including allelic losses in specific chromosomal arms, mutations of oncogenes, tumour suppressor genes and mismatch repair genes, micro-satellite instability, and methylation changes in gene promoters [reviewed [1]]. Additionally, CRC is frequently associated with altered splicing of tumour suppressor genes, and genes encoding enzymes, growth factors, cytoskeletal and cell adhesion proteins, hormone and growth factor receptors, and transcription factors [see [2-5]]. Importantly, since different splice variants of a given gene can have different or even antagonistic effects on diverse cellular functions, including apoptosis, proliferation, differentiation, angiogenesis and cell motility, a change in the splice variant ratio may actively contribute to tumour progression. Indeed, positive selection for splice variants that encode isoforms with a selective advantage in tumour progression is of potential diagnostic value and could provide therapeutic targets.
###end p 11
###begin p 12
###xml 234 238 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 570 571 570 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 577 581 577 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 761 762 761 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 763 764 763 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 774 778 774 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 814 818 814 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 937 938 937 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1149 1151 1149 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1173 1177 1173 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1307 1311 1307 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1365 1367 1365 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1368 1370 1368 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1441 1443 1441 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1444 1446 1444 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1498 1500 1498 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1670 1672 1670 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1705 1709 1705 1709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1740 1744 1740 1744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 2003 2004 2003 2004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 2040 2044 2040 2044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 2102 2106 2102 2106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 2207 2211 2207 2211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 2277 2279 2277 2279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 2680 2682 2680 2682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 2818 2820 2818 2820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 2946 2948 2946 2948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 3014 3016 3014 3016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 3254 3256 3254 3256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 3292 3296 3292 3296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 1213 1218 <span type="species:ncbi:9606">human</span>
###xml 1942 1947 <span type="species:ncbi:9606">human</span>
###xml 2453 2458 <span type="species:ncbi:10090">mouse</span>
Ras proteins are low molecular weight (~21 kD) GTPases which cycle between the GDP-bound (inactive) and the GTP-bound (active) state at the plasma membrane, and thereby regulate cell growth, apoptosis, motility and differentiation. K-ras activating point mutations occur in about 50% of human sporadic CRC cases and act by stabilising the active GTP-bound configuration, and so promote cellular transformation by constitutive activation of downstream effector pathways, including Raf kinases, phosphatidylinositol 3-kinases (PI3-K), and RalGDS family members [reviewed [6]]. K-ras activating mutations play a key role in tumour progression and metastasis in CRC by regulating angiogenesis and protease expression, and cell polarity, adhesion and motility [see [7-9]]. The K-ras gene encodes two splice variants, K-ras 4A and 4B, and activating mutations that usually arise at codons 12, 13 or 61, jointly affect both isoforms [reviewed [6]]. Importantly, since K-Ras oncoproteins differentially promote transformation, cell migration, and anchorage-independent growth, they most probably act in a cooperative manner to drive neoplastic progression [10]. The ratio of the K-ras 4A/4B splice variants is reduced in human sporadic CRC in both primary adenocarcinomas and colon cancer cell lines that harbour K-ras activating mutations, including homozygous mutations [11,12]. Since mutationally activated K-Ras 4B has an anti-apoptotic action [13,14] and, unlike K-Ras 4A, can promote cell migration [10], and K-Ras 4B can drive expression of matrix metalloproteinase 2 (MMP-2) which specifically cleaves type IV collagen, and is involved in cell detachment and migration [15], the altered splicing of the K-ras oncogene in CRC in favour of K-ras 4B could contribute to neoplastic progression by enabling the survival of cells with DNA damage and facilitating tumour invasion and, ultimately, metastasis. Indeed, tumour growth and metastasis in human CRC is linked with increased expression of MMP-2 [see [7]]. However, the finding that the K-ras 4A/4B ratio is also reduced in CRC cell lines that lack K-ras activating mutations raises the possibility that a regulated switch in alternative splicing of the K-ras proto-oncogene may also have a causal role in tumour progression [12]. The mechanism could involve increased expression of MMP-2 (see above), and/or reduced apoptosis given that the K-Ras 4A proto-oncoprotein exerts a pro-apoptotic action in mouse intestine following etoposide-induced DNA damage, and evidence that the K-Ras proto-oncoproteins have antagonistic effects on apoptosis in embryonic stem (ES) cells: Ras 4A promotes, whereas K-Ras 4B inhibits, apoptosis [16]. Further, while K-Ras 4B, and probably K-Ras 4A, promote ES cell differentiation following withdrawal of leukaemia inhibitory factor [16] it is unlikely they do so with similar efficiency since the Raf/MAPK pathway regulates stem cell differentiation [reviewed [17]] and K-Ras 4A and 4B differ in their ability to activate Raf-1 [10]. Therefore, in accordance with the 'stem cell model' for cancer formation we proposed that a change in the ratio of K-Ras proto-oncoproteins may further contribute to neoplastic progression by perturbing stem cell differentiation [see [12]]. Thus, altered splicing of the K-ras proto-oncogene could drive tumour progression in sporadic CRC by promoting MMP-2 expression, and inappropriate stem cell survival and self-renewal.
###end p 12
###begin p 13
###xml 180 184 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 208 211 208 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 211 231 211 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
###xml 257 261 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 285 287 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 308 311 300 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 311 317 303 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+ </sup>
###xml 318 321 310 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 403 407 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc </italic>
###xml 557 561 549 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc </italic>
###xml 579 581 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 657 660 649 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 660 665 652 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 669 672 661 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 672 676 664 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 680 683 672 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 683 688 675 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 692 695 684 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 695 715 687 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
###xml 752 756 736 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 808 811 792 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 811 831 795 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
###xml 849 851 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 852 854 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 879 883 855 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 905 909 881 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 931 933 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 978 982 954 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1020 1022 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1084 1088 1060 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 1104 1106 1080 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1179 1187 1155 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">absence </italic>
###xml 1239 1243 1215 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 715 719 <span type="species:ncbi:10090">mice</span>
###xml 831 835 <span type="species:ncbi:10090">mice</span>
###xml 883 887 <span type="species:ncbi:10090">mice</span>
###xml 1088 1092 <span type="species:ncbi:10090">mice</span>
To address the hypothesis that alteration in the ratio of the K-Ras proto-oncoproteins in favour of K-Ras 4B can affect tumour formation in the small intestine in the absence of K-ras activating mutations, K-rastmDelta4A/tmDelta4A mice, which express the K-ras 4B splice variant only [18], were crossed with ApcMin/+ (Min) mice. The latter mice harbour a heterozygous germ-line nonsense mutation in the Apc (adenomatous polyposis coli) tumour suppressor gene, and are predisposed to developing multiple intestinal tumours initiated by loss of the wild-type Apc allele [reviewed [19]]. By this means tumorigenesis in the small intestine was compared between ApcMin/+, K-ras+/+ and ApcMin/+, K-rastmDelta4A/tmDelta4A mice that can, and cannot, express K-ras 4A respectively. This approach was selected since K-rastmDelta4A/tmDelta4A mice are healthy [16,18], intestinal tumours in Min mice do not harbour K-ras activating mutations [20], and K-Ras 4A deficiency does not affect K-ras 4B expression in the small intestine [16] where, importantly, most (> 95%) intestinal tumours form in Min mice [reviewed [19]]. Thus, the effect of K-Ras 4A on tumorigenesis can be examined in the absence both of its oncogenic allele and of alteration in K-ras 4B expression as a consequence of K-Ras 4A deficiency.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 15
###begin p 16
###xml 182 188 182 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+ </sup>
###xml 277 280 277 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 280 300 280 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
###xml 336 338 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 365 368 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 368 372 360 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 422 425 414 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 425 435 417 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A </sup>
###xml 585 588 573 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 588 608 576 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
###xml 656 664 636 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pla2g2a </italic>
###xml 672 677 652 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mom-1</italic>
###xml 711 713 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 726 731 706 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 735 738 715 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 738 742 718 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 747 750 727 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 754 757 734 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 757 777 737 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
###xml 795 798 767 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 798 803 770 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 807 810 779 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 810 822 782 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/+ </sup>
###xml 826 829 794 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 829 832 797 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 836 839 804 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 839 851 807 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/+ </sup>
###xml 862 865 826 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 865 870 829 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 874 877 838 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 877 889 841 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/+ </sup>
###xml 919 922 879 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 922 925 882 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 929 932 889 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 932 944 892 900 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/+ </sup>
###xml 973 976 929 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 976 981 932 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 985 988 941 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 988 992 944 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 996 999 952 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 999 1004 955 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 1008 1011 964 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 1011 1031 967 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
###xml 1068 1071 1016 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 1071 1075 1019 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 1176 1179 1124 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 1179 1183 1127 1131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 1198 1200 1146 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1209 1213 1157 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1266 1270 1214 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1318 1321 1266 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 1321 1331 1269 1275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A </sup>
###xml 1356 1360 1300 1304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 1386 1390 1330 1334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1450 1452 1394 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1501 1502 1445 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1524 1527 1468 1471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 1527 1532 1471 1476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 1536 1539 1480 1483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 1539 1543 1483 1487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1547 1550 1491 1494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 1550 1555 1494 1499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 1559 1562 1503 1506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 1562 1582 1506 1518 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
###xml 1633 1635 1569 1571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1816 1819 1752 1755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 1819 1824 1755 1760 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 1828 1831 1764 1767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 1831 1835 1767 1771 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1865 1868 1801 1804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 1868 1873 1804 1809 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 1877 1880 1813 1816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 1880 1900 1816 1828 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
###xml 2049 2051 1977 1979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 300 305 <span type="species:ncbi:10090">mouse</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
###xml 851 855 <span type="species:ncbi:10090">mice</span>
###xml 889 893 <span type="species:ncbi:10090">mice</span>
###xml 944 948 <span type="species:ncbi:10090">mice</span>
###xml 1042 1046 <span type="species:ncbi:10090">Mice</span>
###xml 1473 1477 <span type="species:ncbi:10090">mice</span>
###xml 1582 1586 <span type="species:ncbi:10090">mice</span>
###xml 1638 1642 <span type="species:ncbi:10090">Mice</span>
###xml 1790 1794 <span type="species:ncbi:10090">mice</span>
###xml 1835 1839 <span type="species:ncbi:10090">mice</span>
###xml 1900 1904 <span type="species:ncbi:10090">mice</span>
###xml 1968 1972 <span type="species:ncbi:10090">mice</span>
###xml 2074 2078 <span type="species:ncbi:10090">mice</span>
All animal work was carried out using procedures approved by the ethical panel of the University of Edinburgh and licensed by the Home Office (Project licence PPL60/3433). Inbred ApcMin/+ mice (C57BL/6) were obtained from The Jackson Laboratory (Bar Harbor, Maine, USA). The K-rastmDelta4A/tmDelta4A mouse has been reported previously [18]. Since penetrance of the ApcMin mutation is affected by genetic background, the K-rastmDelta4A allele on a F1(129/Ola x C57BL/6) background was backcrossed for a further 8 generations on to the susceptible C57BL/6 inbred background. Resultant K-rastmDelta4A/tmDelta4A mice were confirmed as congenic for the C57BL/6 Pla2g2a allele (Mom-1) by PCR as described previously [21]. Inbred ApcMin/+, K-ras+/+ x Apc+/+, K-rastmDelta4A/tmDelta4A crosses generated ApcMin/+, K-rastmDelta4A/+ and Apc+/+, K-rastmDelta4A/+ mice. Male ApcMin/+, K-rastmDelta4A/+ mice were crossed with female Apc+/+, K-rastmDelta4A/+ mice to generate informative ApcMin/+, K-ras+/+ and ApcMin/+, K-rastmDelta4A/tmDelta4A offspring. Mice heterozygous for the ApcMin allele were identified by PCR as described previously that generates a wild-type (123 bp) and mutant ApcMin (144 bp) band [22]. The K-ras genotype was determined using primers that amplify K-ras exon 4A, and primers that identify the mutant K-rastmDelta4A allele by amplifying the neo cassette which replaces K-ras exon 4A, that generate 72 bp and 206 bp bands respectively [18]. The genotyping of mice is summarised in Table 1. Survival curves for ApcMin/+, K-ras+/+ and ApcMin/+, K-rastmDelta4A/tmDelta4A mice were compared using the Mantel-Haenszel test [23]. Mice were culled immediately on showing signs of intestinal neoplasia, including anaemia, pale feet, hunching and/or swollen abdomen. A small number of mice (3 male and 4 female ApcMin/+, K-ras+/+ mice, and 4 male and 2 female ApcMin/+, K-rastmDelta4A/tmDelta4A mice) with rectal prolapse, which were immediately culled, and also mice randomly withdrawn for tumour counts were treated as censored observations [23]. Reclassification of mice with prolapse as uncensored observations did not affect any of the conclusions of the study.
###end p 16
###begin p 17
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 27 32 27 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 39 51 39 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/+ </sup>
###xml 53 56 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 56 59 52 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 63 66 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 66 78 62 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/+ </sup>
###xml 110 113 102 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 113 118 105 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 122 125 114 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 125 129 117 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 133 136 125 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 136 141 128 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 145 148 137 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 148 168 140 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
Genotyping litters from ApcMin/+, K-rastmDelta4A/+ x Apc+/+, K-rastmDelta4A/+ crosses to identify informative ApcMin/+, K-ras+/+ and ApcMin/+, K-rastmDelta4A/tmDelta4A offspring
###end p 17
###begin p 18
+/- = PCR product present/absent respectively (see Methods)
###end p 18
###begin title 19
Histology
###end title 19
###begin p 20
###xml 22 24 22 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 141 148 141 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">en face</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were killed by CO2 asphyxiation and the small intestine removed, flushed with phosphate buffered saline, opened lengthwise, and mounted en face. Following fixation for 4 hours in methacarn (4 volumes methanol, 2 volumes chloroform and 1 volume glacial acetic acid) the number and area of all visible tumours was scored using a dissection microscope at 10x magnification.
###end p 20
###begin p 21
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
For examination of tumour pathology, "gut roll" preparations were made from mice with overt signs of neoplasia as described above, fixed in 10% buffered formalin, wax embedded, and stepped serial sections stained with haematoxylin and eosin. Mitotic and apoptotic counts were defined as the mean number of mitotic or apoptotic figures in a single high-power (x 400) microscope field within each of ten adenomas of the small intestine of comparable size and dysplasia in preparations from five or six individual mice (of both sexes combined) of each genotype, counting only intra-epithelial figures and avoiding debris in glandular lumina and any non-neoplastic epithelium on the adenoma surface.
###end p 21
###begin p 22
###xml 81 82 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Tumour number, area, and mitotic and apoptotic counts were compared by Student's t-test.
###end p 22
###begin title 23
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
Analysis of K-ras mutations by PCR-direct sequencing
###end title 23
###begin p 24
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
DNA was prepared from individual tumours dissected from the small intestine and screened for the presence of K-ras mutations at codons 12, 13 and 61 as described previously [20].
###end p 24
###begin title 25
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 27 30 27 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
Analysis of K-ras 4A and K-ras 4B transcript expression levels by quantitative RT-PCR
###end title 25
###begin p 26
###xml 688 699 669 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin </italic>
###xml 815 819 793 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 938 942 916 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1008 1012 986 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1105 1109 1083 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1149 1153 1127 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1206 1210 1184 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1216 1220 1194 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1227 1238 1205 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin </italic>
###xml 1553 1557 1528 1532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1566 1570 1541 1545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1657 1668 1632 1640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin </italic>
###xml 1963 1967 1935 1939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1976 1980 1948 1952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 2070 2074 2042 2046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 2083 2087 2055 2059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 2215 2219 2187 2191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 2228 2232 2200 2204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 2313 2317 2285 2289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 682 687 <span type="species:ncbi:10090">mouse</span>
###xml 807 812 <span type="species:ncbi:10090">mouse</span>
###xml 930 935 <span type="species:ncbi:10090">mouse</span>
###xml 1141 1146 <span type="species:ncbi:10090">mouse</span>
###xml 2341 2346 <span type="species:ncbi:10090">mouse</span>
Normal small intestinal tissue samples and tumours (at least 2 mm diameter, from mice with overt signs of neoplasia as described above, care being taken to avoid Peyer's patches) were dissected and frozen in "RNA later" buffer (Sigma) for subsequent RNA extraction. Total RNA (100 ng) was reverse transcribed in 25 mul volume using the iTaq SYBR Green RT-PCR kit (Bio-Rad) following the manufacturer's instructions. All real-time quantitative reverse transcription polymerase chain reactions (RT-qPCR) were amplified starting with denaturation at 95degreesC for 3 min, then 45 cycles of 95degreesC for 15 sec and 60degreesC for 1 min. The following exon-spanning primers were used: mouse beta-actin upstream primer (5'-AAGCTGTGCTATGTTGCTCTAGACT-3'), and downstream primer (5'-CACTTCATGATGGAATTGAATGTAG-3'); mouse K-ras 4A upstream primer (5'-CCTGGTAGGGAATAAGTGTGATTTG-3'), and downstream primer (5'-GTACTGTCGGATCTCTCTCACCAAT-3'); mouse K-ras 4B upstream primer (5'-GAGTAAAGGACTCTGAAGATGTGCC-3') located in K-ras exon 3, and downstream primer (5'-CATCGTCAACACCCTGTCTTGTCTT-3') that spans the junction of K-ras exon 3 and 4B (specific for the mouse K-ras 4B transcript). The PCR product sizes derived from K-ras 4A, K-ras 4B and beta-actin transcripts were 185 bp, 158 bp and 148 bp respectively. The specificities of the PCR reactions were confirmed by dissociation curve analysis and 2% agarose gel electrophoresis. All PCR products were analysed when in the exponential phase of PCR amplification. Quantification of the relative expression levels of K-ras 4A and K-ras 4B transcripts was performed using standard curves with normalization against those of beta-actin transcripts from the same sample. The relative values were corrected for dilution factors and then corrected for the differences in size of 4A and 4B amplified products. Because the DNA binding affinities of the PCR primers and the sizes of the amplified products were closely similar for the K-ras 4A and K-ras 4B PCR reactions, and the standard curves also showed that the PCR efficiencies for the K-ras 4A and K-ras 4B PCR reactions were very similar at 74.8% and 76.1% respectively, the expression levels of these two different transcripts, K-ras 4A and K-ras 4B, can be compared relative to each other, setting the level of expression of K-ras 4A in wild-type C57BL/6 mouse lung as an arbitrary value of 1.0.
###end p 26
###begin title 27
Results
###end title 27
###begin p 28
###xml 7 11 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 198 202 198 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 388 392 388 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 445 447 445 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 493 497 491 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 543 547 539 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 590 594 586 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 635 636 631 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 376 380 <span type="species:ncbi:10090">mice</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
Both K-ras splice variants are expressed in mouse small intestine [18,24]. In the present study the relative levels of the K-ras 4A and 4B transcripts were quantified by real-time RT-qPCR analysis. Min mice were examined at 8 weeks-old before they showed any visible sign of intestinal tumorigenesis and, for control purposes, comparisons were made with age-matched wild-type mice. The K-ras 4A/4B transcript ratio did not differ significantly (P = 0.95) between wild-type (1.07 +/- 0.09) and Min (1.07 +/- 0.15) mice, and in both cases the K-ras 4A transcript accounted for about 50% of K-ras expressed in the small intestine (Figure 1).
###end p 28
###begin p 29
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 187 190 185 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 190 196 188 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+ </sup>
###xml 197 200 195 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 0 250 0 248 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Real-time RT-qPCR analysis showing relative expression of the K-<italic>ras </italic>4A and 4B transcripts (mean &#177; SD) in small intestine (duodenum) from 8 week-old, inbred (C57BL/6) wild-type (WT) and <italic>Apc</italic><sup>Min/+ </sup>(<italic>Min</italic>) mice (6 male mice were analysed in each cohort).</bold>
###xml 276 280 274 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 307 311 305 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
Real-time RT-qPCR analysis showing relative expression of the K-ras 4A and 4B transcripts (mean +/- SD) in small intestine (duodenum) from 8 week-old, inbred (C57BL/6) wild-type (WT) and ApcMin/+ (Min) mice (6 male mice were analysed in each cohort). Light (stippled) bars, K-ras 4A; dark (hatched) bars, K-ras 4B.
###end p 29
###begin p 30
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 141 142 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 197 201 197 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 256 258 256 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 340 344 340 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 361 365 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 381 383 381 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 417 421 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 481 485 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 532 536 532 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 637 641 637 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 848 852 848 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 930 932 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1085 1088 1085 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 1088 1093 1088 1093 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 1097 1100 1097 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 1100 1104 1100 1104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1108 1111 1108 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 1111 1116 1111 1116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 1120 1123 1120 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 1123 1143 1123 1135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
###xml 1202 1206 1194 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 1218 1220 1210 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1488 1491 1480 1483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 1491 1496 1483 1488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 1500 1503 1492 1495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 1503 1507 1495 1499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1522 1525 1514 1517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 1525 1530 1517 1522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 1534 1537 1526 1529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 1537 1556 1529 1540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A</sup>
###xml 1727 1728 1711 1712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1785 1788 1769 1772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 1788 1793 1772 1777 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 1797 1800 1781 1784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 1800 1804 1784 1788 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1805 1807 1789 1791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 1816 1819 1800 1803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 1819 1824 1803 1808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 1828 1831 1812 1815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 1831 1851 1815 1827 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
###xml 1852 1854 1828 1830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 2141 2144 2117 2120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 2144 2149 2120 2125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 2153 2156 2129 2132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 2156 2159 2132 2135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 2167 2170 2143 2146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 2170 2175 2146 2151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 2179 2182 2155 2158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 2182 2201 2158 2169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A</sup>
###xml 2209 2211 2177 2179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 2262 2264 2230 2232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 2319 2322 2287 2290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 2322 2327 2290 2295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 2331 2334 2299 2302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 2334 2338 2302 2306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 2342 2345 2310 2313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 2345 2350 2313 2318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 2354 2357 2322 2325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 2357 2377 2325 2337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
###xml 2417 2418 2377 2378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 2439 2440 2397 2398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 2440 2442 2398 2400 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 2477 2478 2433 2434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 2478 2480 2434 2436 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 858 863 <span type="species:ncbi:10090">mouse</span>
###xml 1143 1147 <span type="species:ncbi:10090">mice</span>
###xml 1206 1211 <span type="species:ncbi:10090">mouse</span>
###xml 1269 1273 <span type="species:ncbi:10090">Mice</span>
###xml 1694 1698 <span type="species:ncbi:10090">mice</span>
###xml 1859 1863 <span type="species:ncbi:10090">mice</span>
###xml 2377 2381 <span type="species:ncbi:10090">mice</span>
The reduced K-ras 4A/4B splice variant ratio in sporadic human CRC involves down-regulation of K-ras 4A expression [11]. In Min mice (Figure 2), while there was no significant difference between K-ras 4A and 4B transcript levels in normal small intestine (P = 0.383), tumours of the small intestine showed significantly reduced levels of K-ras 4A relative to K-ras 4B transcripts (P = 0.0015). However, the reduced K-ras 4A/4B splice ratio was due to an increase in the level of K-ras 4B transcript expression, while the level of K-ras 4A transcripts was not appreciably altered. While this provides no support for the hypothesis that K-ras 4A plays a role in modulating intestinal tumorigenesis, it does not exclude this hypothesis, which is worthy of further examination given the high expression levels and established pro-apoptotic action of K-ras 4A in mouse intestine and the antagonistic effects of the 4A and 4B isoforms [16]. Therefore, to determine if the K-Ras 4A proto-oncoprotein can modulate tumorigenesis in the small intestine comparisons were made between age-matched ApcMin/+, K-ras+/+ and ApcMin/+, K-rastmDelta4A/tmDelta4A mice. Since gender may influence tumour development in the Min mouse [see [25]] males and females were considered separately. Mice were sampled randomly from the stock at 106 days when the stock was outwardly healthy, and at 152 days when 17% (19/112) of the stock had been either found dead or necessitated necropsy due to sickness [20% (12/59)ApcMin/+, K-ras+/+ and 13% (7/53) ApcMin/+, K-rastmDelta4A/tmDelta4A]. Examination of the small intestine revealed a similar overall tumour number, and no difference in tumour size for both male and female mice at either time point (Table 2). Histological analysis of intestinal preparations from ApcMin/+, K-ras+/+ (n = 8) and ApcMin/+, K-rastmDelta4A/tmDelta4A (n = 7) mice with overt signs of neoplasia revealed that all tumours from both genotypes were adenomas of similar, mild to moderate, dysplasia, with no evidence of invasive carcinoma in any of them. There was no statistically significant difference between the genotypes in mitotic counts (ApcMin/+, K-ras+/+: 25.3; ApcMin/+, K-rastmDelta4A/tmDelta4A: 26.8; P = 0.468) or apoptotic counts (both genotypes: 2.1; P = 1.0) in the tumours. Consistent with the tumour data ApcMin/+, K-ras+/+ and ApcMin/+, K-rastmDelta4A/tmDelta4A mice exhibited similar survival (Figure 3) for both males (chi21 = 1.91, P = 0.167) and females (chi21 = 0.44, P = 0.506).
###end p 30
###begin p 31
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 61 66 61 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 73 77 73 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 81 84 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 84 89 84 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 93 96 93 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 96 116 96 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
Tumorigenesis in the small intestine of outwardly healthy ApcMin/+, K-ras+/+ and ApcMin/+, K-rastmDelta4A/tmDelta4A mice
###end p 31
###begin p 32
###xml 20 22 20 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 20 22 20 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></sup>
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs.</italic>
###xml 25 27 25 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c </italic>
###xml 25 27 25 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>c </italic></sup>
###xml 27 29 27 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 36 38 36 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 36 38 36 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs.</italic>
###xml 41 43 41 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d </italic>
###xml 41 43 41 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d </italic></sup>
###xml 43 45 43 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 53 55 53 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e </italic>
###xml 53 55 53 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>e </italic></sup>
###xml 55 58 55 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs.</italic>
###xml 58 60 58 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 58 60 58 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>g </italic></sup>
###xml 60 62 60 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 70 72 70 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 70 72 70 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>f </italic></sup>
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs.</italic>
###xml 75 77 75 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h </italic>
###xml 75 77 75 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>h </italic></sup>
###xml 77 79 77 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 87 89 87 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i </italic>
###xml 87 89 87 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>i </italic></sup>
###xml 89 92 89 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs.</italic>
###xml 92 94 92 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 92 94 92 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k </italic></sup>
###xml 94 96 94 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
M, male; F, female. a vs.c P = 0.42;b vs.d P = 0.20; e vs.g P = 0.090;f vs.h P = 0.21; i vs.k P = 0.34;
###end p 32
###begin p 33
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">j </italic>
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>j </italic></sup>
###xml 2 5 2 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs.</italic>
###xml 5 7 5 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">l </italic>
###xml 5 7 5 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>l </italic></sup>
###xml 7 9 7 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 17 19 17 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m </italic>
###xml 17 19 17 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>m </italic></sup>
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs.</italic>
###xml 22 24 22 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">o </italic>
###xml 22 24 22 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>o </italic></sup>
###xml 24 26 24 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 34 36 34 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 34 36 34 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>n </italic></sup>
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs.</italic>
###xml 39 41 39 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 39 41 39 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p </italic></sup>
###xml 41 43 41 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 61 62 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
j vs.l P = 0.60; m vs.o P = 0.28; n vs.p P = 0.27 (Student's t-test in each case).
###end p 33
###begin p 34
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 205 208 203 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 208 214 206 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+ </sup>
###xml 0 249 0 247 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Real-time RT-qPCR analysis showing relative expression of the K-<italic>ras </italic>4A and 4B transcripts (mean &#177; SD of 6 samples in each case) in normal small intestine (SI) and tumours of the small intestine (SIT) of <italic>Apc</italic><sup>Min/+ </sup>mice with overt signs of neoplasia.</bold>
###xml 275 279 273 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 306 310 304 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
Real-time RT-qPCR analysis showing relative expression of the K-ras 4A and 4B transcripts (mean +/- SD of 6 samples in each case) in normal small intestine (SI) and tumours of the small intestine (SIT) of ApcMin/+ mice with overt signs of neoplasia. Light (stippled) bars, K-ras 4A; dark (hatched) bars, K-ras 4B.
###end p 34
###begin p 35
###xml 23 26 23 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 26 31 26 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 38 42 38 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 48 50 48 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 86 88 86 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 125 128 125 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 128 133 128 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 137 140 137 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 140 160 140 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
###xml 166 168 158 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 204 206 196 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 0 240 0 232 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Survival curve showing <italic>Apc</italic><sup>Min/+</sup>, K-<italic>ras</italic><sup>+/+ </sup>mice [<italic>n </italic>= 20 males (heavy continuous line), <italic>n </italic>= 8 females (heavy broken line)] and <italic>Apc</italic><sup>Min/+</sup>, K-<italic>ras</italic><sup>tm&#916;4A/tm&#916;4A </sup>mice [<italic>n </italic>= 10 males (light continuous line), <italic>n </italic>= 16 females (light broken line)].</bold>
###xml 254 256 246 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
Survival curve showing ApcMin/+, K-ras+/+ mice [n = 20 males (heavy continuous line), n = 8 females (heavy broken line)] and ApcMin/+, K-rastmDelta4A/tmDelta4A mice [n = 10 males (light continuous line), n = 16 females (light broken line)]. In each case n refers to the number of uncensored observations.
###end p 35
###begin p 36
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc </italic>
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 340 343 340 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 343 348 343 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 352 355 352 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 355 359 355 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 381 384 381 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 384 389 384 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 393 396 393 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 396 408 396 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/+ </sup>
###xml 433 436 429 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 436 441 432 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 445 448 441 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 448 468 444 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm&#916;4A/tm&#916;4A </sup>
###xml 511 515 499 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 468 472 <span type="species:ncbi:10090">mice</span>
Previous studies have established that intestinal tumours from Apc mutant mice, including adenocarcinomas, do not harbour K-ras activating mutations [20,26,27]. In confirmation, and to establish this applies in compound mutant Min mice, K-ras codons 12, 13 and 61 were sequenced in 27 small intestinal tumours, that included 8 tumours from ApcMin/+, K-ras+/+ mice, 15 tumours from ApcMin/+, K-rastmDelta4A/+ mice, and 4 tumours from ApcMin/+, K-rastmDelta4A/tmDelta4A mice. No tumours were found to harbour a K-ras activating mutation (data not shown).
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc </italic>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 547 551 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc </italic>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 806 808 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 558 562 <span type="species:ncbi:10090">mice</span>
Because intestinal tumours develop spontaneously in Apc mutant mice they present a powerful model system to study factors that modulate intestinal tumour development, including genetic modifiers, which may be important in the design of potential therapeutic strategies [reviewed [28]]. To date, inactivating mutations in genes involved in arachidonic acid and sphingosine metabolism, DNA methylation, and genes encoding the matrix mellalloproteinase MMP-7, VEGF-A and matricellular proteins have been found to suppress intestinal tumorigenesis in Apc mutant mice. Conversely, inactivating mutations in genes related to genomic stability and DNA mismatch repair, and genes that regulate PI3-K/AKT signalling, and proliferation and differentiation in the crypt-villus axis, promote tumorigenesis [see [19,25,28-38]].
###end p 38
###begin p 39
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 277 281 277 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 357 361 357 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 398 402 398 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 474 478 474 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 627 629 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 694 702 694 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">absence </italic>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 915 917 915 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1073 1075 1073 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1417 1421 1417 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 1535 1537 1535 1537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1887 1891 1887 1891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1955 1957 1955 1957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1958 1960 1958 1960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 2122 2130 2122 2130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">absence </italic>
###xml 2155 2157 2155 2157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 2158 2160 2158 2160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 2290 2293 2290 2293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 2293 2299 2293 2299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+ </sup>
###xml 2336 2340 2336 2340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 2361 2365 2361 2365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 2401 2403 2401 2403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 2411 2415 2411 2415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 2460 2464 2460 2464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 2495 2497 2495 2497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 2498 2500 2498 2500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 361 366 <span type="species:ncbi:10090">mouse</span>
###xml 853 858 <span type="species:ncbi:10090">mouse</span>
###xml 1930 1935 <span type="species:ncbi:9606">human</span>
###xml 1940 1945 <span type="species:ncbi:10090">mouse</span>
###xml 2299 2303 <span type="species:ncbi:10090">mice</span>
###xml 2382 2387 <span type="species:ncbi:10090">mouse</span>
###xml 2542 2546 <span type="species:ncbi:10090">mice</span>
Because homozygosity for the K-ras null allele is embryonic lethal [39] nothing is known about the effect of inactivation of the K-ras proto-oncogene on intestinal homeostasis. The present study found the K-Ras 4A proto-oncoprotein, whose transcript accounts for some 50% of K-ras expressed in the small intestine, does not affect tumour development in the Min mouse intestine where tumours lack K-ras activating mutations. The result is perhaps unexpected given that the K-ras proto-oncogene can promote ES cell differentiation, exert a pro-apoptotic action in ES cells following DNA damage induced by etoposide or cisplatin [16,40,41] and, importantly, can suppress tumour development in the absence [41] as well as the presence [42] of its oncogenic allele. Moreover, the K-Ras 4A proto-oncoprotein exerts a pro-apoptotic action in both ES cells and mouse small intestine following etoposide-induced DNA damage [16]. The failure of K-Ras 4A to affect tumorigenesis may reflect the fact that K-Ras 4A deficiency does not affect baseline levels of apoptosis in the crypt [16] and/or abolish completely the apoptotic response in the small intestine following DNA damage, but rather it is reduced and delayed, which implies activation of K-Ras 4A-independent apoptotic pathways. The complex relationship between apoptosis and cancer development is highlighted by recent evidence that the tumour suppressor activity of p53 in radiation-induced lymphoma is not dependent on its ability to promote apoptosis and so eliminate mutant cells [43]. Therefore, the K-Ras 4A-mediated pro-apoptotic response in the small intestine following etoposide-induced DNA damage could be irrelevant for tumour formation and, indeed, it does not necessarily follow that K-Ras 4A has a pro-apoptotic action at physiological levels of DNA damage, or with other types of DNA damage. Thus, while the pattern of K-ras 4A expression is strongly conserved in human and mouse tissues [12,18] its role in intestinal homeostasis remains unclear. However, given that K-Ras 4B can promote ES cell differentiation and suppress mammary carcinogenesis in the absence of its oncogenic allele [16,44] it remains to be determined whether K-Ras 4B can suppress intestinal tumorigenesis. This would necessitate a comparison between ApcMin/+ mice that can, and cannot, express K-ras 4B. However, since K-ras is essential for mouse development [39] and K-ras 4B is the major splice variant and, unlike K-ras 4A, is expressed ubiquitously [12,18], it is doubtful that K-Ras 4B-deficient mice would be viable, and therefore such a study would require conditional inactivation.
###end p 39
###begin p 40
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 129 133 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 291 295 291 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 409 418 409 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 485 489 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 519 523 519 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 805 809 805 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 989 993 989 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 1094 1098 1094 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 1109 1111 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1112 1114 1112 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1115 1117 1115 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1118 1120 1118 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1225 1229 1225 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1269 1273 1269 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1288 1290 1288 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1304 1308 1304 1308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 1325 1329 1325 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1363 1367 1363 1367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1411 1415 1411 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1478 1479 1478 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1491 1492 1491 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1503 1507 1503 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1539 1543 1539 1543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1581 1583 1581 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1599 1603 1599 1603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1616 1620 1616 1620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1672 1674 1672 1674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1675 1677 1675 1677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1727 1731 1727 1731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1775 1779 1775 1779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1853 1857 1853 1857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 1968 1972 1968 1972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 2000 2003 2000 2003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 2036 2043 2036 2043 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se </italic>
###xml 2084 2088 2084 2088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 2109 2113 2109 2113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 2175 2179 2175 2179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 2310 2314 2310 2314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 2346 2347 2346 2347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 2370 2374 2370 2374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 2430 2432 2430 2432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 2433 2435 2433 2435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 2544 2548 2544 2548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 834 839 <span type="species:ncbi:10090">mouse</span>
###xml 993 997 <span type="species:ncbi:10090">mice</span>
###xml 1098 1102 <span type="species:ncbi:10090">mice</span>
###xml 1180 1185 <span type="species:ncbi:9606">human</span>
###xml 1308 1313 <span type="species:ncbi:10090">mouse</span>
In sporadic CRC the K-ras 4A/4B splice variant ratio is reduced in colon cancer cell lines, regardless of whether they harbour K-ras activating mutations [11,12]. Since the K-ras 4A/4B ratio is reduced in primary CRC tumours [12] the altered ratio in cell lines, including those that lack K-ras activating mutations, is more likely to be symptomatic of the tumours from which they were derived rather than an in vitro artefact of the growth conditions. While altered splicing of the K-ras proto-oncogene in favour of K-ras 4B could, conceivably, modulate tumour progression, and possibly by effects on MMP-2 expression, apoptosis and/or differentiation (see Background), the present study found that alteration in the ratio of the K-Ras proto-oncoproteins in favour of K-Ras 4B (by targeted deletion of K-ras exon 4A) does not affect mouse survival or tumour number, size or histopathology (including mitotic and apoptotic counts). These observations are unlikely to reflect the fact that Min mice die before intestinal tumours can progress, since adenocarcinomas do develop in compound mutant Min mice [see [19,29-31,36]]. They could relate to the fact that the altered ratio in human CRC involves not only an decrease in K-ras 4A expression but also an increase in K-ras 4B expression [11]: indeed, in Min mouse tumours, K-ras 4B expression is elevated while K-ras 4A expression is not appreciably altered. K-ras 4B expression was unaffected in the comparisons shown in Table 2 and Figure 3 because K-ras 4A deficiency does not affect K-ras 4B expression in the small intestine [16]. Given that K-ras 4B, unlike K-ras 4A, can promote cell migration and MMP2 expression [10,15], the possibility that increased expression of K-ras 4B, with or without reduced expression of K-ras 4A, is an essential component for tumour progression in cases that lack K-ras activating mutations remains to be addressed. Although the present study establishes that a reduction in the K-ras 4A/4B ratio does not affect Apc-driven intestinal tumorigenesis per se the finding that the ratio is reduced in Min adenomas that lack K-ras activating mutations raises the intriguing possibility that K-ras may have a more widespread role in tumorigenesis in addition to that in lung, colon and pancreatic cancers that normally harbour K-ras activating mutations [reviewed [6]]. Thus, given that K-ras 4A and 4B are co-expressed widely in mammalian tissues [12,18] it remains to be determined whether their ratio is altered in other types of tumours that routinely lack K-ras activating mutations.
###end p 40
###begin title 41
Conclusion
###end title 41
###begin p 42
###xml 204 212 204 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">absence </italic>
Even though the K-Ras 4A proto-oncoprotein exerts a pro-apoptotic action in the small intestine following etoposide-induced DNA damage, it does not affect tumour development, albeit when expressed in the absence of its oncogenic allele.
###end p 42
###begin title 43
Competing interests
###end title 43
###begin p 44
The authors declare that they have no competing interests.
###end p 44
###begin title 45
Authors' contributions
###end title 45
###begin p 46
###xml 181 186 <span type="species:ncbi:10090">mouse</span>
CEP, study design, performed experimental studies, drafted the manuscript; MJA & FL, real-time RT-qPCR analysis, histopathology, edited the manuscript; LR, MW, PSD, RLB, NJL & RAR, mouse breeding, genotyping and tumour studies; OJS, contribution to study design, provision of cDNAs, edited the manuscript; MLH, statistical analysis, edited the manuscript. All authors read and approved the final manuscript.
###end p 46
###begin title 47
Pre-publication history
###end title 47
###begin p 48
The pre-publication history for this paper can be accessed here:
###end p 48
###begin p 49

###end p 49
###begin title 50
Acknowledgements
###end title 50
###begin p 51
The study was supported by Cancer Research UK (CUK) Project grant C5/A4318 awarded to C.E.Patek, D.J.Harrison and M.L.Hooper. We are grateful to Alan Clarke for helpful discussion.
###end p 51
###begin article-title 52
Colorectal cancer: a multipathway disease
###end article-title 52
###begin article-title 53
The connection between splicing and cancer
###end article-title 53
###begin article-title 54
Unbalanced alternative splicing and its significance in cancer
###end article-title 54
###begin article-title 55
Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array
###end article-title 55
###begin article-title 56
Alternative splicing in cancer: Noise, functional, or systematic ?
###end article-title 56
###begin article-title 57
RAS oncogenes: the first 30 years
###end article-title 57
###begin article-title 58
Matrix metallo-proteinase-2 and tissue inhibitor of metalloproteinase-2 in colorectal carcinoma invasion and metastasis
###end article-title 58
###begin article-title 59
###xml 10 16 10 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K-RAS </italic>
Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells
###end article-title 59
###begin article-title 60
Control of colorectal metastasis formation by K-Ras
###end article-title 60
###begin article-title 61
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 5 10 <span type="species:ncbi:9606">human</span>
Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility
###end article-title 61
###begin article-title 62
Detecting changes in the relative expression of KRAS2 splice variants using polymerase colonies
###end article-title 62
###begin article-title 63
###xml 2 6 2 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 43 48 <span type="species:ncbi:9606">human</span>
K-ras 4A and 4B are co-expressed widely in human tissues, and their ratio is altered in sporadic colorectal cancer
###end article-title 63
###begin article-title 64
###xml 78 84 78 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K-Ras </italic>
Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumour suppressor genes
###end article-title 64
###begin article-title 65
###xml 113 118 <span type="species:ncbi:10090">mouse</span>
Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models
###end article-title 65
###begin article-title 66
K-Ras regulates the steady-state expression of matrix metalloproteinase 2 in fibroblasts
###end article-title 66
###begin article-title 67
###xml 116 120 <span type="species:ncbi:10090">mice</span>
The K-Ras 4A isoform promotes apoptosis but does not affect either lifespan or spontaneous tumor incidence in aging mice
###end article-title 67
###begin article-title 68
Signalling, cell cycle and pluripotency in embryonic stem cells
###end article-title 68
###begin article-title 69
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
While K-ras is essential for mouse development, expression of the K-ras 4A splice variant is dispensable
###end article-title 69
###begin article-title 70
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 44 50 44 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+ </sup>
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Multistep carcinogenesis of the colon in ApcMin/+ mouse
###end article-title 70
###begin article-title 71
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Somatic mutational mechanisms involved in intestinal tumor formation in Min mice
###end article-title 71
###begin article-title 72
###xml 11 13 11 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Loss of Apc+ in intestinal adenomas from Min mice
###end article-title 72
###begin article-title 73
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 40 46 <span type="species:ncbi:10090">murine</span>
Developmentally-regulated expression of murine K-ras isoforms
###end article-title 73
###begin article-title 74
###xml 74 80 70 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+ </sup>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Intestinal-specific PPARgamma deficiency enhances tumorigenesis in the ApcMin/+ mice
###end article-title 74
###begin article-title 75
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc </italic>
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ras </italic>
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tp53 </italic>
###xml 118 121 118 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 146 149 146 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 130 135 <span type="species:ncbi:10090">mouse</span>
Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis
###end article-title 75
###begin article-title 76
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Dextran sodium sulfate strongly promotes colorectal carcinogenesis in Apc(Min/+) mice: inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms
###end article-title 76
###begin article-title 77
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse models of gastrointestinal tumors
###end article-title 77
###begin article-title 78
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specifically of modifiers
###end article-title 78
###begin article-title 79
EphB receptor activity suppresses colorectal cancer progression
###end article-title 79
###begin article-title 80
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 35 41 35 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+ </sup>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Colonic tumourigenesis in BubR1/ApcMin/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability
###end article-title 80
###begin article-title 81
Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation
###end article-title 81
###begin article-title 82
###xml 16 20 <span type="species:ncbi:10090">mice</span>
Kaiso-deficient mice show resistance to intestinal cancer
###end article-title 82
###begin article-title 83
###xml 62 68 62 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+ </sup>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Deficiency of SPARC suppresses intestinal tumorigenesis in APCMin/+ mice
###end article-title 83
###begin article-title 84
###xml 89 92 89 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 92 98 92 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/Min </sup>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc+/Min mice
###end article-title 84
###begin article-title 85
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTEN </italic>
###xml 72 78 72 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+ </sup>
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
Heterozygous disruption of the PTEN promotes intestinal neoplasia in APCMin/+ mouse: roles of osteopontin
###end article-title 85
###begin article-title 86
Atm is a negative regulator of intestinal neoplasia
###end article-title 86
###begin article-title 87
Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity
###end article-title 87
###begin article-title 88
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
K-ras is an essential gene in the mouse with partial functional overlap with N-ras
###end article-title 88
###begin article-title 89
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
Mutant K-ras enhances apoptosis in embryonic stem cells in combination with DNA damage and is associated with increased levels of p19 (ARF)
###end article-title 89
###begin article-title 90
###xml 2 6 2 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 98 104 <span type="species:ncbi:10090">murine</span>
K-ras proto-oncogene exhibits tumour suppressor activity as its absence promotes tumorigenesis in murine teratomas
###end article-title 90
###begin article-title 91
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Wildtype Kras 2 can inhibit lung carcinogenesis in mice
###end article-title 91
###begin article-title 92
The pathological response to DNA damage does not contribute to p53-mediated tumour suppression
###end article-title 92
###begin article-title 93
###xml 77 81 <span type="species:ncbi:10116">rats</span>
###xml 112 115 <span type="species:ncbi:10116">rat</span>
Decreased susceptibility to MNU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the Harvey ras promoter
###end article-title 93

